文献速递心力衰竭与心肌病瓣膜病与结构性心脏病

女性肥厚型心肌病患者生存率更差

Women with hypertrophic cardiomyopathy have worse survival.
PubMed 文献 · Eur Heart J · 2017-01-01

AIMS: Sex differences in hypertrophic cardiomyopathy (HCM) remain unclear. We sought to characterize sex differences in a large HCM referral centre population.…

要点

  • 女性肥厚型心肌病患者就诊时年龄更大、NYHA III-IV级症状更多。
  • 女性梗阻生理、二尖瓣反流及E/e'比值均高于男性。
  • 女性性别为死亡的独立相关因素(HR 1.13,P=0.01)。

研究设计与样本

  • 采用Kaplan-Meier生存曲线和log-rank检验比较性别间生存率,Cox比例风险回归分析性别与生存的关系。

主要发现

  • 女性就诊时年龄更大(59±16 vs 52±15岁,P<0.0001)。
  • 女性NYHA III-IV级症状比例更高(45.0% vs 35.3%,P<0.0001),梗阻生理更多(77.4% vs 71.8%,P=0.0001),中度及以上二尖瓣反流更多(56.1% vs 43.9%,P<0.0001)。
  • 女性E/e'比值更高(20.6 vs 15.6,P<0.0001),估测肺动脉收缩压更高(40.8±15.4 vs 34.8±10.8 mmHg,P<0.0001)。
  • 女性心肺运动试验表现更差(预测VO2百分比62.8±20% vs 65.8±19.2%,P=0.007),接受酒精室间隔消融更频繁(4.9% vs 3.0%,P=0.004),但心肌切除术频率相似(28% vs 30%,P=0.24)。
  • 中位随访10.9年(IQR 7.4-16.2),Kaplan-Meier分析显示女性生存率低于男性(P<0.0001)。

临床怎么用

  • 女性肥厚型心肌病患者就诊时病情更重,应考虑更积极的诊断和治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Sex differences in hypertrophic cardiomyopathy (HCM) remain unclear. We sought to characterize sex differences in a large HCM referral centre population. METHODS AND RESULTS: Three thousand six hundred and seventy-three adult patients with HCM underwent evaluation between January 1975 and September 2012 with 1661 (45.2%) female. Kaplan-Meier survival curves were assessed via log-rank test. Cox proportional hazard regression analyses evaluated the relation of sex with survival. At index visit, women were older (59 ± 16 vs. 52 ± 15 years, P < 0.0001) had more symptoms [New York Heart Association (NYHA) Class III-IV 45.0% vs. 35.3%, P < 0.0001], more obstructive physiology (77.4% vs. 71.8%, P = 0.0001), more mitral regurgitation (moderate or greater in 56.1% vs. 43.9%, P < 0.0001), higher E/e' ratio (n = 1649, 20.6 vs. 15.6, P < 0.0001), higher estimated pulmonary artery systolic pressure (n = 1783, 40.8 ± 15.4 vs. 34.8 ± 10.8 mmHg, P < 0.0001), worse cardiopulmonary exercise performance (n = 1267; percent VO2 predicted 62.8 ± 20% vs. 65.8 ± 19.2%, P = 0.007), and underwent more frequent alcohol septal ablation (4.9% vs. 3.0%, P = 0.004) but similar frequency of myectomy (28% vs. 30%, P = 0.24). Median follow-up was 10.9 (IQR 7.4-16.2) years. Kaplan-Meier analysis demonstrated lower survival in women compared with men (P < 0.0001). In multivariable modelling, female sex remained independently associated with mortality (HR 1.13 [1.03-1.22], P = 0.01) when adjusted for age, NYHA Class III-IV symptoms, and cardiovascular comorbidities. CONCLUSION: Women with HCM present at more advanced age, with more symptoms, worse cardiopulmonary exercise tolerance, and different haemodynamics than men. Sex is an important determinant in HCM management as women with HCM have worse survival. Women may require more aggressive diagnostic and therapeutic approaches.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Geske JB, Ong KC, Siontis KC, et al. Women with hypertrophic cardiomyopathy have worse survival. Eur Heart J. 2017. PMID: 29020402. doi:10.1093/eurheartj/ehx527

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。